Back to Results
First PageMeta Content
Food and Drug Administration / Pharmaceutical industry / Clinical pharmacology / United States Public Health Service / Aprotinin / Clinical trial / Pharmaceutical sciences / Pharmacology / Clinical research


Transcript of FDA Second Press Conference on Trasylol
Add to Reading List

Open Document

File Size: 57,86 KB

Share Result on Facebook

Company

Bayer Pharmaceuticals / FDA Second Press / /

Country

United States / Canada / /

Event

FDA Phase / /

Facility

FDA Center / /

IndustryTerm

credentialed media / /

MedicalCondition

cardio pulmonary bypass / certain serious allergic reactions / hypersensitivity / /

MedicalTreatment

coronary artery bypass surgery / cardiac surgery / bypass / surgery / blood transfusions / /

Organization

office of Medical Imaging and Hematology / Data Safety Monitoring Committee / Food and Drugs Administrations Office / office of New Drugs / office of Surveillance and Epidemiology / Monitoring Committee / U.S. Food and Drug Administration / FDA Center for Drug Evaluation and Research / Advisory Committee / Office of Surveillance and Epidemiology at FDA Center for Drug Evaluation and Research / Office of New Drugs at FDA Center for Drug Evaluation and Research / /

Person

Andrew Bridges / Peper Long / Susan Edelman / John Jenkins / Dwaine Reeves / John Wilkerson / Gerald Dal Pan / /

Position

CT Coordinator / Governor / Coordinator / Director / /

Product

Trasylol / /

Technology

Medical Imaging / /

URL

www.FDA.gov / /

SocialTag